DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Misoprostol
Misoprostol
Mid Trimester Termination; Pgf2 Alpha Versus Misoprostol
Postpartum Haemorrhage
NAF's 2015 Clinical Policy Guidelines
MEDICATION ABORTION Overview of Research & Policy in the United States
Taking Misoprostol
Misoprostol Induces Relaxation of Human Corpus Cavernosum Smooth Muscle: Comparison to Prostaglandin E1
What Is Medical Abortion? Mifepristone Or Methotrexate, a Second Drug, Misoprostol, Is Taken
A Randomized Controlled Trial of Misoprostol and Sulprostone to End Pregnancy After Fetal Death
Diclofenac Sodium/Misoprostol) Tablets
Application for Inclusion on WHO Model List of Essential Medicines
Oral Titrated Misoprostol for Induction of Labor: Anmc
Dinoprostone and Misoprostol for Induction of Labour Pak Armed Forces Med J 2016; 66(5):631-36
Interruption of Nonviable Pregnancies of 24–28 Weeks' Gestation Using Medical Methods Release Date June 2013 SFP Guideline #20133
Medical Termination of Pregnancy
Medication Abortion a Guide for Health Professionals
How to Take the Pills for Your Abortion and What to Expect
MIFEPREX (Mifepristone) Tablets, for Oral Use Initial U.S
Dilatation & Evacuation (D&E) Reference Guide
Top View
Safe Abortion: Technical and Policy Guidance for Health Systems Evidence Summaries and GRADE Tables
Misoprostol Inhibits Gastric Mucosal Release of Endogenous Prostaglandin E2 and Thromboxane B2
Misoprostol Use and Its Impact on Measuring Abortion Incidence and Morbidity Katherine S
Medication for Second Trimester Pregnancy Loss Or Abortion
Cytotec (Misoprostol) Administration to Women Who Are Pregnant Can Cause Abortion, Premature Birth, Or Birth Defects
MISOPROSTOL TREATMENT for MISCARRIAGE Overview Benefits
Descriptions of Methods of Pregnancy Termination
Treatment of Miscarriage with Misoprostol/Cytotec
Mifepristone/Misoprostol Abortion Protocol
Effects of Misoprostol and Prostaglandin E2 on Proteoglycan Biosynthesis and Loss in Unloaded and Loaded Articular Cartilage Explants
Mifepristone and Misoprostol for Medical Abortion
A Molecular Docking of New 9Β-Halogenated Prostaglandin Analogues †
Safety Profile of Misoprostol for Obstetrical Indications
Misoprostol and Mifeprinstone Medical Termination and Or Fetal Death
Be an Alternative to Prostaglandin E2 (PGE2) for Induction of Labor in Prelabor Rupture of Membranes (PROM) After 34 Weeks Period of Gestation
A Comparative Study of Efficacy of Misoprostol with Methyl Ergometrine and Carboprost in Active Management of Third Stage of Labour
Uterine Atony Is Failure of the Uterus to Contract Following Delivery and Is a Common Cause of Postpartum Hemorrhage
Comparing Two Regimens of in Travaginal Misoprostol With
Preparing for Your Procedure with Misoprostol
Uterotonics for the Prevention of Postpartum Haemorrhage
A Randomized Clinical Trial to Compare the Efficacy of Different Doses Of
Misoprostol for Nonviable Pregnancy– Instructions for Patients
Abortion Using Misoprostol Pills a GUIDE for ALL PREGNANT PEOPLE SEEKING to SELF-MANAGE THEIR ABORTION (SMA)
Abortion with Self-Administered Misoprostol: a Guide for Women
Misoprostol for the Purpose of Midtrimester Termination of Pregnancy: a Comparative Study with Prostaglandin F2 Alpha with Oxytocin Infusion
Essential Medicines List Application Mifepristone–Misoprostol for Medical Abortion
Facts About Mifepristone (RU-486) • the Clinician Evaluates the Woman to Confirm a Complete
Section B Changed Classes/Guidelines Final Version
Cervical Ripening for First Trimester Abortion: a Comparative Study Between Misoprostol and Carboprost 125 Micrograms
UTEROTONIC AGENTS FACT SHEET Larry Shields, MD, Central Coast Maternal Fetal Medicine
Labor Induction Abortion in the Second Trimester Release Date February 2011 SFP Guideline 20111
Medical Abortion: Follow-Up at Home After Receiving Mifepristone
The Facts on Mifepristone
Expert Committee
Clinical Study a Randomized Controlled Trial of Misoprostol and Sulprostone to End Pregnancy After Fetal Death
Cervical Preparation for Surgical Abortion from 20 to 24 Weeks' Gestation Release Date 12 December 2007 SFP Guideline 20073
Clinical Practice Handbook for Safe Abortion
Medical Management of Abortion
Misoprostol for the Induction of Labour at Term